Subhasree Nag
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Ubiquitin and proteasome pathways 4
- Cancer therapeutics and mechanisms 3
- Ginseng Biological Effects and Applications 3
- Cancer-related gene regulation 2
- Oncology 11
- Cancer-related Molecular Pathways 9
- Co-authors
- Ruiwen Zhang (18 shared papers)Jiang‐Jiang Qin (13 shared papers)Wei Wang (1 shared paper)Satyan Kalkunte (1 shared paper)Sukesh Voruganti (11 shared papers)Jianwei Zhou (3 shared papers)Ming‐Hai Wang (5 shared papers)Kalkunte S. Srivenugopal (2 shared papers)
- Journals
- Current Medicinal Chemistry (3 papers)PLoS ONE (2 papers)Current Cancer Drug Targets (2 papers)Oncotarget (2 papers)Chemical Research in Toxicology (2 papers)
- Partner nations
- United StatesChina
In The Last Decade
Subhasree Nag
24 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 318
- Oncology 520
- Molecular Biology 1.2k
- Toxicology 58
- Pharmacology 142
Countries citing papers authored by Subhasree Nag
This map shows the geographic impact of Subhasree Nag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhasree Nag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhasree Nag more than expected).
Fields of papers citing papers by Subhasree Nag
This network shows the impact of papers produced by Subhasree Nag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhasree Nag. The network helps show where Subhasree Nag may publish in the future.
Co-authors
The 25 scholars most cited alongside Subhasree Nag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 320 | |
| 2 | 2012 | 297 | |
| 3 | 2014 | 213 | |
| 4 | 2014 | 174 | |
| 5 | 2014 | 123 | |
| 6 | 2014 | 100 | |
| 7 | 2015 | 85 | |
| 8 | 2014 | 83 | |
| 9 | 2012 | 76 | |
| 10 | 2015 | 59 | |
| 11 | 2012 | 49 | |
| 12 | 2014 | 45 | |
| 13 | 2013 | 40 | |
| 14 | 2012 | 29 | |
| 15 | 2013 | 26 | |
| 16 | 2021 | 21 | |
| 17 | 2017 | 19 | |
| 18 | 2019 | 16 | |
| 19 | 2014 | 12 | |
| 20 | 2013 | 9 |
About Subhasree Nag
Subhasree Nag is a scholar working on Molecular Biology, Oncology, Cancer Research, Pharmacology and Cell Biology, having authored 24 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (9 papers), Ubiquitin and proteasome pathways (4 papers), Estrogen and related hormone effects (3 papers), Cancer therapeutics and mechanisms (3 papers), Ginseng Biological Effects and Applications (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Microtubule and mitosis dynamics (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (318 citations), Oncology (520 citations), Molecular Biology (1.2k citations), Toxicology (58 citations) and Pharmacology (142 citations). Subhasree Nag has collaborated with scholars based in United States and China. Frequent co-authors include Ruiwen Zhang, Jiang‐Jiang Qin, Wei Wang, Satyan Kalkunte, Sukesh Voruganti, Jianwei Zhou, Ming‐Hai Wang, Kalkunte S. Srivenugopal, Xu Zhang and Wei Wang. Their work appears in journals such as Current Medicinal Chemistry, PLoS ONE, Current Cancer Drug Targets, Oncotarget and Chemical Research in Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.